Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

Not Applicable

Recruiting

• Conditions: Alzheimer Disease

• Registration Number: NCT06728436
• Lead Sponsor: University of Kansas Medical Center

Brief Summary

The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos.

Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences .

Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-12-06
• Study First Submitted QC: 2024-12-06
• Study First Posted: 2024-12-11
• Status Verified: 2025-02
• Study Start: 2025-02-17
• Last Update Submitted: 2025-02-17
• Last Update Posted: 2025-02-20
• Primary Completion: 2029-05
• Study Completion: 2029-05

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 288

Inclusion Criteria

• Over the age of 18
• Spanish and English-speaking people who identify as Latino
• Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment
• Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
• Self-reports being able to read and write
• Owns a cell phone with a flat fee, and uses it at least weekly for texting.

Exclusion Criteria

• Participation in another wellbeing-related clinical trial
• Cohabitation with another participant in the CuidaTEXT R01 Study
• Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study
• Participant plans to move to another country within seven months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in caregiver depressive symptoms	Baseline and 6 months	Change in caregiver depressive symptoms from baseline to 6 months as measured by the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10). The CES-D-10 is a self-report rating scale that measures characteristic symptoms of depression in the past week (e.g. depression, loneliness). Each item is rated on a 4-point scale (Rarely or None of the Time-Most or All of the Time). The summary score ranges from 0 to 30 with higher scores indicating higher severity.

Secondary Outcome Measures

Name	Time	Method
Change in caregiver behavioral distress symptoms	Baseline and 6 months	Change in caregiver behavioral distress symptoms from baseline to 6 months as measured by the Neuropsychiatric Inventory-Questionnaire (NPI-Q).If any of 12 care recipient behavioral symptoms is present in the last month (e.g., repeating, delusions), caregivers rate their own distress on a 6-point scale (Not at All-Extreme). A distress summary score is calculated by adding the scores of all items, with scores ranging from 0 to 60. Higher scores indicate higher distress.

Trial Locations

Locations (1)

University of Kansas Medical Center; 🇺🇸 Fairway, Kansas, United States